Fractures of pace-sense electrodes in implantable cardioverterdefibrillator patients are a common cause of inappropriate shocks. To reduce inappropriate shocks, we developed a lead-integrity alert (LIA) triggered by either oversensing or high impedance that can be downloaded into previously implanted implantable cardioverterdefibrillators. This prospective study tested the hypothesis that the LIA would reduce the percentage of patients who receive inappropriate shocks compared with a concurrent control group monitored by impedance only. Each group included a prospectively determined sample size of 213 consecutive patients with fractures confirmed by structural analysis of explanted leads. The LIA group had a 46% relative reduction (95% confidence interval 34% to 55%) in the percentage of patients with Ն1 inappropriate shock (LIA 38% versus control 70%, PϽ0.001) and a 50% relative reduction (95% confidence interval 33% to 61%) in the percentage with Ն5 shocks (25% versus 50%, PϽ0.001). These data show that a software download that upgrades previously implanted implantable cardioverterdefibrillators without surgical revision reduces inappropriate shocks caused by lead fractures. See p 1449.
Anomalous Mitral Arcade in Twin-Twin Transfusion Syndrome
Twin-twin transfusion syndrome is an important cause of perinatal mortality in monochorionic twins, often because of cardiovascular compromise associated with increased intravascular volume in the recipient twin. In this autopsy study of 11 sets of twins with the condition, 4 recipient twins had anomalous mitral arcade, a rare fibrotic valve lesion that is associated with regurgitation. Previously unrecognized in twin-twin transfusion syndrome, anomalous mitral arcade may explain many of the progressive hemodynamic abnormalities in this condition. From this retrospective clinicopathological correlation study, ultrasound/echocardiographic evidence of left atrial dilation and significant mitral regurgitation in the recipient should raise suspicion for anomalous mitral arcade, a structural lesion that likely will not reverse after successful laser treatment or delivery of the fetus, as other hemodynamic and functional abnormalities often do. Thus, for perinatologists and fetal echocardiographers who manage patients with twin-twin transfusion syndrome, the present study suggests that acquired mitral arcade is likely a physiologically important lesion that may have prognostic significance in recipient twins. For pediatric cardiologists and scientists who study cardiac development, the occurrence of anomalous mitral arcade in this specific population and the progressive deterioration of hemodynamics in affected recipients militate against developmental arrest as the cause of the valve lesion. Anomalous mitral arcade likely represents a flow-related or acquired valve deformity, not a malformation. See p 1456.
Association Between Prehospital Time Intervals and ST-Elevation Myocardial Infarction System Performance
Currently, there is little guidance on how emergency medical services should optimize their time before hospital arrival when caring for ST-elevation myocardial infarction patients. This study analyzed the association between 5 prehospital system time intervals and achieving a goal time to percutaneous coronary intervention of Յ90 minutes. Our findings imply that developing prehospital time benchmarks for important patient care-related variables may further enhance quality improvement for ST-elevation myocardial infarction care systems. It is important to recognize that not all of the individual prehospital time components may be feasible for implementation in any 1 emergency medical service system. Focusing on individual components with an overall design for implementation may prove beneficial for emergency medical service systems attempting to improve ST-elevation myocardial infarction care. Although an STelevation myocardial infarction care system includes many more components than the benchmarks included in this study, these benchmarks may serve as plausible starting points for emergency medical service systems process improvement in ST-elevation myocardial infarction care. See p 1464.
Exhaled Carbon Monoxide and Risk of Metabolic Syndrome and Cardiovascular Disease in the Community
Carbon monoxide (CO) is widely recognized as a potentially toxic byproduct of hydrocarbon combustion. More recently, CO has been recognized as a key second messenger molecule that is normally present in the body at low concentrations and serves to protect the cardiovascular system against oxidative, inflammatory, and vascular stresses. Thus, elevated levels of endogenous CO may reflect the presence of underlying metabolic and cardiovascular pathology. We assessed the association of exhaled CO (a marker of endogenous CO) with the presence of cardiometabolic risk factors cross-sectionally and with the risk of developing future metabolic syndrome and overt cardiovascular disease prospectively among 4139 individuals (contributing 14 943 person-examinations) in the Framingham Heart Study. We observed that exhaled CO was associated with the presence of metabolic syndrome (Pϭ0.01) in addition to many of its component risk factors. During up to 4 years of follow-up, baseline CO was also associated with future cardiometabolic events, with individuals in the highest quartile of exhaled CO having a Ϸ1.5 odds of developing metabolic syndrome (PϽ0.0001) and Ϸ1.7 risk of developing cardiovascular disease (Pϭ0.008) compared with the lowest quartile, serving as referent. Overall, the findings of this study suggest that elevated CO is an important marker for the development of both metabolic disease and cardiovascular disease. Additional research is warranted to elucidate how CO-related pathways may contribute to cardiometabolic disorders and their associated outcomes. See p 1470.
Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate-and Low-Cardiovascular-Risk Individuals for Statin Therapy
Recent studies suggest that extending statin therapy for primary prevention to relatively younger and healthier individuals (10-year Framingham risk as low as 5%) may be effective, but there are concerns about the cost and potential harms from more aggressive drug treatment. It has been proposed that using additional risk markers such as high-sensitivity C-reactive protein (hs-CRP) levels may be useful in selecting lower-risk individuals for statin treatment. The present study used a simulation model to compare the clinical and economic outcomes of current Adult Treatment Panel III (ATP-III) guidelines, a strategy of hs-CRP screening with statin treatment only in those with elevated levels, and a strategy of starting statin therapy at lower risk levels without hs-CRP testing. This study shows that although hs-CRP screening is preferable to current ATP-III guidelines, simply starting statin therapy at lower risk levels without hs-CRP screening would further improve clinical outcomes at acceptable cost, making it the optimally cost-effective strategy. Screening with hs-CRP would be the most cost-effective strategy only if it could identify people for whom statin therapy is not effective in reducing risk, thereby sparing them from unnecessary treatment. The model also demonstrated that expanded use of statins for primary prevention is reasonable only if their use in low-risk individuals is extremely safe; even slight increases in harms from treatment would make current ATP-III guidelines the optimal strategy for primary prevention. More research is needed to define the long-term safety of statins and to determine whether hs-CRP can identify nonresponders to statin therapy. See p 1478.
Chymase Inhibition Prevents Fibronectin and Myofibrillar Loss and Improves Cardiomyocyte Function and LV Torsion Angle in Dogs With Isolated Mitral Regurgitation
The volume overload of isolated mitral regurgitation currently has no recommended therapy that improves left ventricular function or delays the need for surgery. Numerous studies in animal models have demonstrated extracellular matrix loss, rather than accumulation, in the pathophysiology of progressive left ventricular remodeling in a pure volume overload. Thus, blockade of the renin-angiotensin system has not proved successful in a situation of volume overload, in which collagen loss and cardiomyocyte slippage may occur early in the course of left ventricular remodeling. Chymase, in addition to formation of angiotensin II, can activate matrix metalloproteinases and directly degrade matricellular proteins important not only in connections to collagen but also in the initiation of detrimental intracellular signaling processes. Thus, blockade of chymase may prove to be an important therapeutic target in a pure volume overload. See p 1488.
Risk Score for In-Hospital Ischemic Stroke Mortality Derived and Validated Within the Get With The Guidelines-Stroke Program
Ischemic stroke is one of the top causes of mortality in the United States, and much of this mortality occurs during hospital admission. Determining an individual patient's risk of mortality at admission could aid clinical care by providing valuable prognostic information to patients and their family members. Third-party payers and regulatory agencies have shown increasing interest in tracking stroke mortality as a marker of care, so adjustment for baseline risk of mortality will be necessary to avoid penalizing hospitals that admit less healthy patient populations. Therefore, there is an increasingly important need to develop well-validated models that are useful in predicting patient risk of mortality from ischemic stroke. In this study, data from the US nationwide Get With The Guidelines-Stroke Registry, sponsored by the American Heart Association, were used to develop a risk score for in-hospital ischemic stroke mortality using information routinely available at the time of admission. The model was developed in more than 160 000 patients and then validated in another 110 000. Ischemic stroke patients at low, intermediate, and high risk for in-hospital mortality can be identified with the validated model. A major finding was that the addition of a measure of stroke severity, the National Institutes of Health Stroke Scale score, greatly improved the ability to discriminate between patients who died and patients who survived. Reporting of the risk score has been implemented within Get With The Guidelines-Stroke by use of computerized decision support via a World Wide Web-based tool, so that hospitals can now access automated calculations of individual or aggregate mortality risk. See p 1496.
Pathophysiology of Tricuspid Regurgitation: Quantitative Doppler Echocardiographic Assessment of Respiratory Dependence
Tricuspid regurgitation (TR) is present in most humans in variable degrees, but its pathophysiology is poorly understood. Previous clinical observations suggested that the murmur of TR may vary with respiration, but the reality, magnitude, pathophysiology, and clinical implications of this potential variation with respiration have not been investigated. However, progress in Doppler echocardiographic assessment of TR with instantaneous quantification of its degree and quantification of cardiac cavity changes, coupled with the ability to record the respiratory phases with a respirometer, allowed us to obtain unique insights into the pathophysiology of TR. Applying these methods, we first observed that TR is indeed markedly dynamic but with complex changes of opposite directions. Indeed, during inspiration, TR driving force and duration decrease, but because this decline is more than compensated for by a considerable increase in effective regurgitant orifice, TR volumetric severity increases with inspiration by Ͼ100%. The marked effective regurgitant orifice inspiratory increase is in turn due to reduced valve coverage of an enlarging annulus and increased valve tenting, resulting in reduced valve coaptation. These valve changes causing TR inspiratory augmentation are in turn linked to right ventricular shape changes with inspiratory right ventricular widening. These profound pathophysiological respiratory changes, poorly detected clinically, underscore the TR respiratory dependence linked to valve deformation and right ventricular plasticity. In practice, the major respiratory variation of TR requires multiplying measurements throughout the cardiac cycle to appropriately assess TR and right ventricular pressure. See p 1505.
